Top 10 Books about Stock Investing to read in 2018. Read more.

PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#1891()/6711

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE 1.48%
PRICE $6.16
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Progenics Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 6.57% ( 2018-01-31 )
Cash 477.5 mill
Loans 99.2 mill
Beta 3.18
ROA -35.07
Buy candidate since 2018-02-22 Gain 1.48%

Progenics Pharmaceuticals Inc. gained 1.48% in the last trading day, rising from $6.07 to $6.16 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 9 of the last 10 days and is up by 15.14% over the past 2 weeks. Volume fell in the last day by -823 854 shares, and in total, 950 725 shares bought and sold for approximately $5.86 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Access today's Top 5 Buy Candidates

Trend

Progenics Pharmaceuticals Inc. lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.55% during the next 3 months and, with 90% probability hold a price between $5.29 and $6.94 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Progenics Pharmaceuticals Inc. holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $5.93 and $6.02. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 08, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 69 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Progenics Pharmaceuticals Inc. finds support from accumulated volume at $6.15. On the upside the stock meets some resistance just above today's level from accumulated volume at $6.27, $6.28 and $6.29.

The stock is about to test the resistance from accumulated volume at $6.27 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $6.15 Price: $6.16 Resistance: $6.27

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.19 between high and low, or 3.18%. For the last week, the stock has had a daily average volatility of 4.29%.

Our recommended stoploss: $5.91 (-3.99%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 10 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Trade PGNX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL